Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2018

View Archived Issues

Kinase interplay prevents ALS

Parkin, PINK keep inflammation pout of the red zone

Brain-on-three-chips includes BBB

Unexpected asthma mechanism changes targeting calculus

Nilotinib improves biomarkers of Parkinson's disease in phase II study

Koligo introduces Kyslecel to preserve insulin secretory capacity after total pancreatectomy

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

EGFR tyrosine kinase inhibitor from UCLA crosses the blood-brain barrier

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

University of Michigan describes bromodomain and extra-terminal protein inhibitors

Seoul National University patents 4'-phosphopantetheinyl transferase inhibitors

G-0775: An arylomycin class Gram-negative antibiotic

Zai Lab discontinues development of ZL-3101 for atopic dermatitis

European Commission approves Vyxeos for two types of high-risk AML

Evotec and Centogene establish drug discovery collaboration in rare genetic diseases

European Commission approves Kymriah

Yescarta approved in E.U. for relapsed or refractory DLBCL and PMBCL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...